One reason these benefits are so effective is that metformin inhibits the activity of the mTOR (mechanistic target ... spots ...

[31] Deforolimus, a novel mTOR inhibitor, was tested in a group of 55 relapsed/refractory patients with different hematological malignancies (mostly acute leukemia). [32] Interestingly, activity ...